After gefitinib treatment, the tumors formed by NSCLC cells with SQSTM1 knockdown were much smaller than those formed by NSCLC cells without SQSTM1 knockdown (Fig. 3b, c). Here, SQSTM1 is linked to non-small cell lung carcinoma.